• ptx_challenge
    We challenge
    ourselves to
    think differently
    Learn More
  • ptx_inspire
    We inspire each
    other to enhance
    the lives of patients
    Learn More
  • ptx_access
    We provide access
    to life-changing
    Learn More

Our Company

Pernix Therapeutics (NASDAQ: PTX) is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market.

Pernix Therapeutics promotes its branded products to Healthcare Providers through its internal sales force and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceuticals, L.L.C. and Cypress Pharmaceuticals, Inc.

Our Medicines

Pernix Therapeutics is dedicated to addressing unmet needs within central nervous system (CNS) indications, including pain, neurology, and psychiatry, as well as other specialty therapeutic areas.